82042
Albumin; urine, quantitative, each specimen
CPT code 82042 represents a quantitative laboratory test to measure the concentration of albumin in a urine specimen. Albumin is a vital protein synthesized in the liver, and under normal physiological conditions, the kidneys effectively filter and reabsorb most of it, leading to very minimal excretion in urine. The presence of elevated albumin in urine, a condition known as albuminuria, is a critical indicator of potential kidney damage, particularly to the glomeruli, which are the kidney's primary filtering units. When albumin levels are moderately increased, it is often referred to as microalbuminuria. This quantitative test provides a precise numerical value of albumin concentration, which can be reported in various units, such as milligrams per 24 hours for timed collections or as an albumin-to-creatinine ratio (UACR) for spot urine samples. The UACR is particularly valuable as it helps normalize albumin excretion by accounting for variations in urine concentration due to hydration status, thereby providing a more reliable assessment. Early detection of albuminuria is paramount, especially in individuals with chronic conditions like diabetes mellitus, hypertension, and autoimmune diseases, as it can serve as an early warning sign for the development or progression of chronic kidney disease (CKD) and an independent risk factor for cardiovascular disease. The test aids clinicians in several ways: monitoring disease progression, evaluating the efficacy of therapeutic interventions (e.g., blood pressure control, glycemic management, use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers), and guiding treatment adjustments aimed at preserving renal function and slowing CKD progression. The typical methodology for this test involves automated immunoassay techniques, such as nephelometry or turbidimetry, performed in a clinical laboratory. The urine specimen can be collected as a random spot sample, a first-morning void (often preferred for screening due to higher concentration), or a timed collection like a 24-hour urine, depending on clinical necessity and laboratory protocols.
Clinical Indications
- Screening for and monitoring of chronic kidney disease (CKD) progression, particularly in high-risk populations such as those with diabetes or hypertension.
- Diagnosis and management of diabetic nephropathy in patients with Type 1 or Type 2 diabetes mellitus.
- Assessment of renal involvement and progression in individuals with hypertension.
- Monitoring the effectiveness of renoprotective therapies, such as ACE inhibitors or ARBs, in patients diagnosed with albuminuria.
- Evaluation of individuals with risk factors for cardiovascular disease, as albuminuria is an independent prognostic marker.
- Assessment of renal function in patients with autoimmune diseases, including lupus nephritis.
- Investigation of unexplained edema, proteinuria, or other signs of renal dysfunction.
- Screening for pre-eclampsia and other renal complications in pregnant women.
- Monitoring kidney health in patients receiving potentially nephrotoxic medications.
Procedure Steps
- **Specimen Collection:** The patient is provided with clear instructions for hygienic urine collection. Depending on the clinical indication, a random spot urine sample, a first-morning void, or a timed collection (e.g., 24-hour urine) is collected in a sterile, leak-proof container. For UACR, a first-morning void is often preferred.
- **Specimen Handling and Transport:** Collected urine samples are properly labeled with patient identifiers, date, and time. If analysis is not immediate, the sample is refrigerated. Specimens are then transported to the laboratory promptly under appropriate temperature conditions.
- **Laboratory Analysis:** Upon receipt, an aliquot of the urine sample is prepared for testing. Quantitative measurement of albumin is performed using an automated immunoassay method (e.g., nephelometry, turbidimetry, immunoturbidimetric assays) that specifically detects and quantifies albumin proteins.
- **Calibration and Quality Control:** The assay is meticulously performed with established calibration standards and quality control materials to ensure the accuracy and precision of the results.
- **Creatinine Measurement (if UACR):** If an albumin-to-creatinine ratio (UACR) has been ordered, urine creatinine (billed separately with CPT 82570 or 82565) is also measured from the same urine specimen.
- **Result Generation and Reporting:** The laboratory instrument generates a quantitative result for urine albumin concentration (e.g., mg/L, µg/min) and/or the calculated UACR (mg/g or mg/mmol). The results, along with appropriate reference ranges and interpretation guidelines, are then reported to the ordering physician.
Coding Guidelines
- CPT code 82042 is specifically for the quantitative measurement of albumin in urine, billed 'each specimen.' This means that if multiple distinct specimens are tested (e.g., baseline and follow-up samples), the code can be billed for each.
- When an albumin-to-creatinine ratio (UACR) is performed, CPT 82042 should be billed for the urine albumin component, and a separate CPT code for urine creatinine (e.g., 82570 for urine creatinine, other source, quantitative; or 82565 for creatinine, other fluid, quantitative) should also be billed.
- The term 'microalbuminuria' refers to a specific range of albumin excretion; CPT 82042 is the appropriate code for quantitative measurement of albumin, regardless of the level. There is no separate CPT code for 'microalbumin.'
- Medical necessity for testing must be clearly documented in the patient's record. This includes using appropriate ICD-10 diagnosis codes that support the indication for the test (e.g., diabetes, hypertension, CKD).
- Frequency of testing should adhere to clinical guidelines and be medically reasonable and necessary. For instance, annual screening for albuminuria is often recommended for diabetic patients.
- CPT 82042 is a specific quantitative test and is generally not bundled with general urinalysis codes (e.g., 81000-81003). If both are performed, they should be billed separately.
Associated ICD-10 Codes
- E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney disease
- E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney disease
- I12.9 - Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
- N18.3 - Chronic kidney disease, stage 3 (moderate)
- I10 - Essential (primary) hypertension
- N18.9 - Chronic kidney disease, unspecified
- R80.9 - Proteinuria, unspecified
- N04.9 - Nephrotic syndrome, unspecified
- M32.14 - End-stage renal disease in systemic lupus erythematosus
- I13.10 - Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
- O13.9 - Gestational [pregnancy-induced] hypertension, unspecified
- E66.9 - Obesity, unspecified
- E78.5 - Hyperlipidemia, unspecified
- Z13.81 - Encounter for screening for other specified cardiovascular, respiratory, and hematological disorders
- Z79.899 - Other long term (current) drug therapy